Advertisement

Picture [iito] Back into Ad 650x80px
Organisation › Details

Mey Capital Matrix GmbH

Founded in 2010, MEY Capital Matrix GmbH is an independent private investment company. The basic idea behind MEY Capital Matrix GmbH involves making entrepreneurial investments in young life science and medical technology companies and offering hands-on support in terms of financial background and management competence. The investor and owner is Gerhard Mey, a dedicated SME entrepreneur. He is co-owner and supervisory board member at one of the world’s 100 top automotive suppliers. MEY Capital Matrix GmbH currently holds investments in five promising young companies. *

 

Period Start 2010-01-01 established
Products Industry private equity
  Industry 2 LIFE SCIENCES
     
Region Region Martinsried
  Country Germany
  Street 3 Hubertusstr.
  City 82152 Planegg
  Tel +49-89-3072-6811
    Address record changed: 2011-10-29
     
Basic data Employees n. a.
     
    * Document for �About Section�: GNA Biosolutions GmbH. (7/1/15). "Press Release: Molecular Diagnostics Specialist GNA Biosolutions Completes € 6 Million (US$ 6.7m) Financing Round". Munich.
     
   
Record changed: 2019-08-08

Advertisement

Picture [iito] Männer Ballett 650x80px

More documents for Mey Capital Matrix GmbH


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

To get even more information, please take a look at our [gs] professional services offering and read the gene-sensor Product Flyer [PDF file]

Please visit also our web portals for the European life sciences and the worldwide mass spectrometry industry at Life-Sciences-Europe.com (European life sciences) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)

Advertisement

Picture EBD Group BioTech Showcase 2021 Whitepaper Presenting 650x80




» top